Fidelity Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Fidelity Investments’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-210,339	Closed	-$24M	–	4381
2019 Q1	$24M	Sell	210,339 -3,681,238	-95%	-$271M	﹤0.01%	1524
2018 Q4	$152M	Sell	3,891,577 -908,073	-19%	-$39.4M	0.02%	684
2018 Q3	$262M	Sell	4,799,650 -736,914	-13%	-$50.4M	0.03%	570
2018 Q2	$458M	Buy	5,536,564 +142,428	+3%	+$11M	0.05%	347
2018 Q1	$359M	Sell	5,394,136 -156,680	-3%	-$9.05M	0.04%	448
2017 Q4	$285M	Buy	5,550,816 +177,099	+3%	+$12.7M	0.03%	552
2017 Q3	$479M	Buy	5,373,717 +707,499	+15%	+$53.7M	0.06%	343
2017 Q2	$279M	Buy	4,666,218 +9,563	+0.2%	+$534K	0.03%	544
2017 Q1	$248M	Buy	4,656,655 +40,698	+0.9%	+$2.42M	0.03%	596
2016 Q4	$230M	Buy	4,615,957 +22,784	+0.5%	+$1.22M	0.03%	610
2016 Q3	$276M	Buy	4,593,173 +93,847	+2%	+$5.41M	0.04%	527
2016 Q2	$230M	Buy	4,499,326 +432,868	+11%	+$18.5M	0.03%	603
2016 Q1	$120M	Buy	4,066,458 +46,914	+1%	+$1.48M	0.02%	886
2015 Q4	$182M	Buy	4,019,544 +335,538	+9%	+$17.6M	0.02%	697
2015 Q3	$154M	Buy	3,684,006 +868,133	+31%	+$45.3M	0.02%	763
2015 Q2	$170M	Buy	2,815,873 +1,244,396	+79%	+$82.3M	0.02%	779
2015 Q1	$122M	Buy	+1,571,477	New	+$90.5M	0.02%	941

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments's ONCE Position: Q2 2019 in Review

Fidelity Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 210,339 shares — an estimated $24M sold.

Fidelity Investments first reported a position in ONCE in Q1 2015 and held it in 17 quarters. The position peaked at $479M in Q3 2017. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

Fidelity Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Fidelity Investments sold 210,339 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $24M.
Fidelity Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 17 quarters.
Fidelity Investments's Spark Therapeutics, Inc. Common Stock position peaked at $479M in Q3 2017.
194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Fidelity Investments's 13F filing for Q2 2019, filed 13 Aug 2019.